Close Menu

The Scan

In PNAS this week: modeling of Rift Valley Fever spillover, Asian mosquito could pose malaria threat, and more.

'Playing It Down'

The editor-in-chief of Science criticizes President Donald Trump for downplaying the COVID-19 pandemic risk.

Review Sought

Politico reports that political appointees are interfering with what appears in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Reports.

Back Up in the UK

After a pause, AstraZeneca has resumed its COVID-19 vaccine clinical trial in the UK, according to NPR.

In PLOS this week: functional effect of adiponectin-linked variants, sequencing reveals regional differences among Swedes, and more.

Oodles of Poodle

A genetic analysis of Australian labradoodles finds they are mostly poodles, the Guardian reports.

Court documents suggest Theranos' Elizabeth Holmes' defense team might rely on "expert evidence relating to a mental disease or defect," CNN reports.

Maryland has ordered 250,000 rapid coronavirus tests, according to the Washington Post.

In Science this week: additional variants linked to development of primary lymphedema, and more.

On Pause

The Washington Post reports AstraZeneca's pausing of its candidate vaccine trial indicates the science is being followed.

Researchers have uncovered more than 175 open-access journals that have disappeared from the internet, Science reports.

Top of the List

CNBC reports NIH Director Francis Collins told a congressional committee that assessing the safety and efficacy of COVID-19 vaccine is the agency's "top priority." 

In Nature this week: analysis of the effect of plasma proteins on disease phenotypes, and more.

WBUR reports Massachusetts has suspended COVID-19 testing at Orig3n following the discovery of "significant certification deficiencies."

John Kingman is to leave as chair of UK Research and Innovation in May, according to the Financial Times.

Watch the Packages

Buzzfeed News reports the University of Washington has warned researchers there to be on the lookout for suspicious packages.

In Cell this week: systems biology analysis of inflammatory syndrome seen in children with COVID-19, single-cell RNA-sequencing strategies, and more.

The Wall Street Journal reports vaccine makers promise to not seek regulatory approval until there is evidence their SARS-CoV-2 vaccines are safe and effective.

Quick Spread

New findings suggest a rapid spread of lactase persistence in Europe, according to Science.

Russian researchers report in the Lancet that their SARS-CoV-2 vaccine leads to an immune response, according to Reuters.

In PNAS this week: possible treatment targets in KRAS-mutated lung cancer, transcriptional analysis of mouse models lacking a p53 inhibitor, and more.

Criteria Not Yet Met

An international committee finds genome editing is not yet ready to be used on human embryos.

The Washington Post discusses how graduate students in the US are affected by the SARS-CoV-2 pandemic and the reopening of universities. 

A German train driver found what turned out to be rodent DNA left on a train, the Associated Press reports.

In Science this week: crystal structures of single-stranded RNA bacteriophages found through metagenomic studies, more.


According to CNBC, Pfizer has announced that its SARS-CoV-2 vaccine data won't be ready this week.

A number of United Nations agencies push for scientific findings to be made accessible through open science.

Paris-Saclay University garners international regard following a decade-long effort to establish the new research university, Nature News reports.

In Nucleic Acids Research this week: database to house IndiGen sequencing data, database of SARS-CoV-2 docking scores, and more.